E3 Ligase Ligand-Linker Conjugates 2
|
泊馬度胺-四聚乙二醇-苯胺
|
1818885-63-0
|
Thalidomide-O-amido-PEG2-C2-NH2 TFA
|
沙利度胺-O-酰胺-二聚乙二醇-氨基三氟乙酸鹽
|
1957235-75-4
|
(S,R,S)-AHPC-C4-NH2 hydrochloride
|
(4R)-N-(5-氨基-1-氧雜戊基)-3-甲基-L-戊基-4-羥基-N-[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酰胺 鹽酸鹽
|
2245697-83-8
|
VH032-PEG3-acetylene
|
VH 032 酰胺-PEG2-炔
|
2098799-80-3
|
E3 Ligase Ligand-Linker Conjugates 52 (TFA)
|
N-(3-氨基丙基)-2-[[2-(2,6-二氧代-3-哌啶基)-1,3-二氧代-4-異吲哚啉基]氧基]乙酰胺三氟乙酸鹽
|
2022182-58-5
|
(S,R,S)-AHPC-Me-C5-COOH
|
7-(((S)-1-((2S,4R)-4-羥基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲?;?吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-7-氧代庚酸
|
2229976-21-8
|
(S,R,S)-AHPC-C10-NH2
|
VH032-C10-NH2
|
2341796-74-3
|
DT2216
|
(2S,4R)-1-((S)-2-(7-(4-((R)-3-((4-(N-(4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氫-[1,1'-聯(lián)苯]-2-基)甲基)哌嗪-1-基)苯甲?;?氨磺酰基)-2-((三氟甲基)磺?;?苯基)氨基)-4-(苯硫基)丁基)哌嗪-1-基)-7-氧代庚酰胺基)-3,3-二甲基丁?;?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺
|
2365172-42-3
|
1-ISOPROPYL-3-METHYL-6-OXO-6,7-DIHYDRO-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID
|
1-異丙基-3-甲基-6-氧代-6,7-二氫-1H-吡唑并[3,4-B]吡啶-4-甲酸
|
1160246-29-6
|
(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid
|
(2S,4R)-1-((S)-2-((叔丁氧基羰基)氨基)-3,3-二甲基丁?;?-4-羥基吡咯烷-2-甲酸
|
630421-46-4
|
ARV-771
|
(2S,4R)-1-((2S)-2-(叔丁基)-15-((6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-基)-4,14-二氧代-6,10-二氧雜-3,13-二氮雜十五烷-1-OYL)-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺
|
1949837-12-0
|
(S,R,S)-AHPC-Me hydrochloride
|
(2S,4R)-1-[(2S)-2-氨基-3,3-二甲基丁酰]-4-羥基-N-[(1S)-1-[4-(4-甲基-1,3-噻唑-5-基)苯基]乙基]吡咯烷-2-甲酰胺鹽酸
|
1948273-03-7
|
E3 ligase Ligand-Linker Conjugates 7
|
(S,R,S)-AHPC-四聚乙二醇-氨基鹽酸鹽
|
2064292-52-8
|
Thalidomide-O-amido-C4-N3
|
沙利度胺 4'-氧乙酰胺-烷基C4-疊氮化物
|
2098488-36-7
|
CCT367766
|
CCT-367766
|
2229856-58-8
|
2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione
|
4-羥基沙利度胺
|
64567-60-8
|
E3 ligase Ligand-Linker Conjugates 5 Free Base
|
(2S,4R)-1-[(S)-14-氨基-2-(叔丁基)-4-氧代-6,9,12-三氧雜-3-氮雜十四烷-1-?;鵠-4-羥基-N-[4-(4-甲基-5-噻唑基)芐基]吡咯烷-2-甲酰胺
|
2010159-56-3
|
BSJ-03-123
|
BSJ-03-123,CDK6降解劑
|
2361493-16-3
|
PROTAC K-Ras Degrader-1
|
PROTAC K-RAS DEGRADER-1
|
2378258-52-5
|
(S,R,S)-AHPC-Me-C6-NH2
|
|
2411422-49-4
|
(S,R,S)-AHPC-C10-NH2 dihydrochloride
|
(2S,4R)-1-((S)-2-(11-氨基戊酰胺基)-3,3-二甲基丁酰基)-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺二鹽酸鹽
|
2341796-75-4
|
Thalidomide-O-amido-PEG-C2-NH2 hydrochloride
|
薩力多胺-O-酰胺-一聚乙二醇-氨基鹽酸鹽
|
2204226-02-6
|
(S,R,S)-AHPC-C4-NH2
|
(2S,4R)-1-((S)-2-(5-氨基戊氨基)-3,3-二甲基丁酰基)-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2138439-53-7
|
(S,R,S)-AHPC-O-Ph-PEG1-NH2
|
(2S,4R)-1-((S)-2-(2-(4-(2-氨基乙氧基)苯氧基)乙酰胺基)-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2361117-24-8
|
1-TOSYL-1H-PYRROLO[2,3-B]PYRIDINE-4-BORONIC ACID PINACOL ESTER
|
1-[(4-甲基苯基)磺?;鵠-4-(4,4,5,5-四甲基-1,3,2-二噁硼
|
916176-50-6
|
4-[5-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
|
4-[5-(4,4,5,5-四甲基-1,3,2-DIOXABOROLAN-2-基)哌啶-2-基]哌嗪-1-羧酸叔丁酯
|
496786-98-2
|
MDK7526
|
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰)-4-羥基-N-(4-(4-甲基噻唑-5-基)苯甲基)吡咯烷-2-甲酰胺
|
1448297-52-6
|
(3R)-4-(2-chloro-6-(1-((R)-S-methylsulfonimidoyl)cyclopropyl)pyrimidin-4-yl)-3-methylmorpholine
|
(3R)-4-(2-氯-6-(1-((R)-S-甲基磺酰亞胺基)環(huán)丙基)嘧啶-4-基)-3-甲基嗎啉
|
1352282-87-1
|
E3 ligase Ligand 1A
|
L-脯氨酰胺,3-甲基-1-纈氨酸-4-羥基-N-[(1S)-1-[4-(4-甲基-5-噻唑基)苯基]乙基]-,(4R)-
|
1948273-02-6
|
(S,R,S)-AHPC-PEG1-N3
|
(4R)-N-[2-(2-疊氮乙氧基)乙?;鵠-3-甲基-L-纈氨?;?4-羥基-N-[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酸酰胺
|
2101200-09-1
|
JQEZ5
|
N-[(1,2-二氫-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-(4-甲基-1-哌嗪基)-3-吡啶基]-1H-吡唑并[3,4-B]吡啶-4-甲酰胺
|
1913252-04-6
|
(S,R,S)-AHPC-PEG3-N3
|
(S,R,S)-AHPC-三聚乙二醇-疊氮
|
1797406-80-4
|
BRD4 degrader AT1
|
2098836-45-2
|
2098836-45-2
|
VH032-PEG5-C6-Cl
|
1799506-06-1
|
1799506-06-1
|
PROTAC BRD9 Degrader-1
|
PROTAC BRD9 DEGRADER-1
|
2097971-01-0
|
Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride
|
沙利度胺-O-酰胺-二聚乙二醇-氨基鹽酸鹽
|
2376990-30-4
|
Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride
|
薩力多胺-O-酰胺-四聚乙二醇-氨基鹽酸鹽
|
2245697-85-0
|
PROTAC BRD4 Degrader-5
|
|
2409538-70-9
|
3,6,9-trioxaundecamethylenediamine
|
3,6,9-三氧雜十一烷-1,11-二胺
|
929-75-9
|
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6R)-
|
2-((6R)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F]的[1,2,4
|
202592-24-3
|
2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione
|
4-氟沙度利安
|
835616-61-0
|
I-BET762 carboxylic acid
|
1300019-38-8
|
1300019-38-8
|
(3R)-4-(2-chloro-6-[(methylsulfinyl)methyl]-4-pyrimidinyl)-3-methylmorpholine
|
(3R)-4-(2-chloro-6-[(methylsulfinyl)methyl]-4-pyrimidinyl)-3-methylmorpholine
|
1352227-18-9
|
dBET57
|
dBET57
|
1883863-52-2
|
(S)-AZD6738
|
(S)-CERALASERTIB
|
1352226-87-9
|
Pomalidomide-C2-NH2 hydrochloride
|
泊馬度胺-C2-氨基鹽酸鹽
|
2305369-00-8
|
(S,R,S)-AHPC-C6-NH2
|
(2S,4R)-1-((S)-2-(7-氨基庚酰胺基)-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2306389-03-5
|
(S,R,S)-AHPC-PEG5-COOH
|
VH 032 酰胺-PEG5-酸
|
2172820-14-1
|
Pomalidomide-amido-PEG3-C2-NH2
|
E3 ligase Ligand-Linker Conjugates 55
|
2328070-52-4
|
MS1943
|
2-(氨基甲基)-1,6-二甲基-3-(苯基甲氧基)-4(1H)-吡啶酮
|
2225938-17-8
|
PROTAC SGK3 degrader-1
|
SGK3 degrader-1
|
2381320-35-8
|
1-METHYL-4-[5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABORALAN-2-YL)PYRIDINE-2-YL]PIPERAZINE
|
2-(4-甲基哌嗪-1-基)吡啶-5-硼酸頻那醇酯
|
918524-63-7
|
2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione
|
2-(2,6-二氧代-哌啶-3-基)-4-氟基-異吲哚-1,3-二酮
|
835616-60-9
|
(R)-methyl 2-chloro-6-(3-methylmorpholino)pyrimidine-4-carboxylate
|
(R)-甲基 2-氯-6-(3-甲基嗎啉代)嘧啶-4-羧酸鹽
|
1233339-69-9
|
MS4078
|
4-[4-[[5-氯-4-[2-[(1-甲基乙基)磺?;鵠氨基]-2-嘧啶基]氨基]-2-甲基-5-(1-甲基乙氧基)苯基]-N-[2-[2-(2,6-二氧代-3-哌啶基)-2,3-二氫-1,3-二氧代-1H-異吲哚-4-基]氨基]乙基]-1-哌啶乙酰胺
|
2229036-62-6
|
(S,R,S)-AHPC-PEG2-NH2
|
(2S,4R)-1 - ((S)-2-(2-(2-(2-氨基乙氧基)乙氧基)乙酰氨基)-3,3-二甲基丁酰基)-4-羥基-N-(4-(4- 甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2010159-60-9
|
(S,R,S)-AHPC
|
(S,R,S)-AHPC
|
2055344-67-5
|
(S,R,S)-AHPC-C4-NH2 dihydrochloride
|
(S,R,S)-AHPC-C4-氨基-二鹽酸鹽
|
2341796-78-7
|
Pomalidomide-PEG4-C-COOH
|
14 - ((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異二氫吲哚-4-基)氨基)-3,6,
|
2097938-44-6
|
MZ 1
|
(4R)-N-[14-[(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f][1,2,4]三唑[4,3-a][1,4]二氮雜卓-6-基]-1,13-二氧代-3,6,9-三氧雜-12-氮雜十四烷基-1-基] -3-甲基-L-纈氨酰-4-羥基-N-[[[4-(4-甲基-5-噻唑基)苯基]甲基]-L-脯氨酰胺
|
1797406-69-9
|
Thalidomide-O-amido-C3-COOH
|
4-(2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰氨基)丁酸
|
2308035-51-8
|
(S,R,S)-AHPC-PEG3-NH2 hydrochloride
|
(S,R,S)-AHPC-PEG3-NH2鹽酸鹽
|
2097971-11-2
|
E3 Ligase Ligand-Linker Conjugates 20 (TFA)
|
N-(8-氨基辛基)-2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰胺2,2,2-三氟乙酸酯
|
1950635-16-1
|
(S)-JQ-35
|
1349719-98-7
|
1349719-98-7
|
Pomalidomide-PEG3-C2-NH2
|
4-((2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)異吲哚-1,3-二酮
|
2093416-31-8
|
Thalidomide-O-amido-C6-NH2 hydrochloride
|
沙利度胺-氧乙酰胺-C6-氨基鹽酸鹽
|
2376990-31-5
|
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride
|
薩力多胺-O-酰胺-三聚乙二醇-氨基鹽酸鹽
|
2245697-84-9
|
1-isopropyl-1H-pyrazol-3-amine
|
3-氨基-1-異丙基吡唑
|
857267-04-0
|
(R)-(-)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate
|
(R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜環(huán)庚烷-6-基)乙酸叔丁酯
|
1268524-71-5
|
Protein degrader 1 hydrochloride
|
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺鹽酸鹽
|
1448189-80-7
|
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)methyl methanesulfonate
|
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)methyl methanesulfonate
|
1233339-71-3
|
(S,R,S)-AHPC-(C3-PEG)2-C6-Cl
|
(S,R,S)-AHPC-C6-PEG1-C3-PEG1-丁基氯
|
1835705-61-7
|
PROTAC BET Degrader-1
|
2093386-22-0
|
2093386-22-0
|
3-((1R,3S,5S)-3-((7-((5-Methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
|
3-((1R,3S,5S)-3-((7-((5-甲基-1H-吡唑-3-基)氨基)-1,6-萘啶-5-基)氨基)-8-氮雜雙環(huán)[3.2.1]辛-8-基)丙腈
|
2051918-33-1
|
(R)-4-(2-chloro-6-(iodomethyl)pyrimidin-4-yl)-3-methylmorpholine
|
(R)-4-(2-氯-6-(碘甲基)嘧啶-4-基)-3-甲基嗎啉
|
1233339-72-4
|
Thalidomide-O-amido-C4-NH2 hydrochloride
|
薩力多胺-O-酰胺-C4-氨基鹽酸鹽
|
2245697-86-1
|
Thalidomide-NH-C4-NH2 TFA
|
薩力多胺-NH-C4-氨基三氟乙酸鹽
|
2093387-50-7
|
5-Bromo-2-(4-Boc-piperazin-1-yl)pyridine
|
1-(5-溴吡啶-2-基)-4-甲基哌嗪
|
364794-58-1
|
5,8,11-Trioxa-2-azatridecanoic,13-amino,1,1-dimethylethyl ester
|
13-氨基-5,8,11-三氧雜-2-氮雜十三烷酸1,1-二甲基乙酯
|
101187-40-0
|
(3R)-4-[2-chloro-6-(methylsulfanylmethyl)pyrimidin-4-yl]-3-methylmorpholine
|
(R)-4-(2-氯-6-((甲硫基)甲基)嘧啶-4-基)-3-甲基嗎啉
|
1352227-15-6
|
(S,R,S)-AHPC-PEG4-NH2
|
(S,R,S)-AHPC-四聚乙二醇-氨基
|
2010159-57-4
|
A1874
|
(6S)-N-[1-[4-[[[(2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-(2,2-二甲基丙基)-2-吡咯烷基]羰基]氨基]-3-甲氧基苯基]-1-氧代-5,8,11-三氧雜-2-氮雜十三烷基-13-基]-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-乙酰胺
|
2064292-12-0
|
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride
|
(S,R,S)-AHPC-PEG2-NH2二鹽酸鹽
|
2341796-76-5
|
(S,R,S)-AHPC-C3-NH2
|
VH032-C3-NH2
|
2361119-88-0
|
(S,R,S)-AHPC-Me-C10-NH2
|
(2S,4R)-1-((S)-2-(11-氨基十一酰胺)-3,3-二甲基丁?;?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5)-基)苯基)乙基)吡咯烷-2-甲酰胺
|
2376139-52-3
|
(R)-(2-chloro-6-(3-methylmorpholino)pyrimidin-4-yl)-methanol
|
(R)-[2-氯-6-[3-甲基(4-嗎啉基)]-4-嘧啶基]甲醇
|
1233339-70-2
|
(S,R,S)-AHPC-PEG2-NH2 hydrochloride
|
(S,R,S)-AHPC-PEG2-NH2鹽酸鹽
|
2097973-72-1
|
(S,R,S)-AHPC-PEG4-N3
|
(S,R,S)-AHPC-四聚乙二醇-疊氮
|
1797406-81-5
|
(S,R,S)-AHPC TFA
|
(2S,4R)-1-((S)-2-氨基-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 2,2,2-三氟乙酸鹽
|
1631137-51-3
|
E3 Ligase Ligand-Linker Conjugates 25 TFA
|
N-(6-氨基己基)-2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰胺2,2,2-三氟乙酸酯
|
1950635-14-9
|
(S,R,S)-AHPC-Me TFA
|
ZB1965
|
2349429-68-9
|
(S,R,S)-AHPC-C5-COOH
|
VH032-C5-COOH
|
2267282-19-7
|
TD-165
|
(2S,4R)-1-((2S)-2-(11-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氨基)十一酰胺基)-3,3-二甲基丁?;?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺
|
2305936-56-3
|
4-(3-Pyridyl)-2-chloropyrimidine
|
4-(3-吡啶基)-2-氯嘧啶
|
483324-01-2
|
AP20187
|
AP 20187,蛋白質(zhì)二聚化的化學(xué)誘導(dǎo)劑
|
195514-80-8
|
5-(6-(3-methoxyoxetan-3-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine
|
5-(6-(3-甲氧基氧雜環(huán)丁烷-3-基)-7-甲基-4-嗎啉基噻吩并[3,2-D]嘧啶-2-基)嘧啶-2-胺
|
1394076-92-6
|
(S,R,S)-AHPC-PEG2-N3
|
(S,R,S)-AHPC-二聚乙二醇-疊氮
|
2010159-45-0
|
Thalidomide-O-amido-PEG3-C2-NH2
|
薩力多胺-O-酰胺-三聚乙二醇-氨基
|
1957236-20-2
|
Pomalidomide-PEG1-C2-N3
|
E3 ligase Ligand-Linker Conjugates 50
|
2271036-44-1
|
Thalidomide-NH-C4-NH-Boc
|
泊馬度胺-NH-C4-氨基叔丁酯
|
2093388-52-2
|